Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| §102 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BATES, KEENAN ALEXANDER | 2 | 44.8% | +76.5% |
| WRIGHT, ERIC BRANDON | 1 | — | — |
| VIJAYARAGHAVAN, JAGAMYA NMN | 1 | 60.0% | +48.2% |
| TAYLOR, LIA ELAN | 1 | 64.5% | +29.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023957 | ANTIBODY AGAINST CORONAVIRUS | TAYLOR, LIA ELAN | 19d |
| 18693293 | METHOD FOR PRODUCING HUMAN ARTIFICIAL CHROMOSOME VECTOR IN HUMAN CELL | WRIGHT, ERIC BRANDON | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18251805 | METHOD FOR PRODUCING REVERSIBLY IMMORTALIZED CELL | VIJAYARAGHAVAN, JAGAMYA NMN | 23d overdue |
| 18023957 | ANTIBODY AGAINST CORONAVIRUS | TAYLOR, LIA ELAN | 19d |
| 18246865 | NOVEL RECOMBINANT VACCINIA VIRUS AND USE THEREOF | BATES, KEENAN ALEXANDER | — |
| 18246592 | ONCOLYTIC VACCINIA VIRUS DEFICIENT IN LARGE REGION OF GENES | BATES, KEENAN ALEXANDER | — |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 1632 | 1 |
| 1633 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18693293 | METHOD FOR PRODUCING HUMAN ARTIFICIAL CHROMOSOME VECTOR IN HUMAN CELL | WRIGHT, ERIC BRANDON | 1632 | §103§112 | Non-Final OA | — | Pending | Mar 19, 2024 |
| 18251805 | METHOD FOR PRODUCING REVERSIBLY IMMORTALIZED CELL | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §103 | Non-Final OA | 23d overdue | Pending | May 04, 2023 |
| 18246865 | NOVEL RECOMBINANT VACCINIA VIRUS AND USE THEREOF | BATES, KEENAN ALEXANDER | 1631 | §103§112DPOther | Non-Final OA | — | Pending | Mar 28, 2023 |
| 18246592 | ONCOLYTIC VACCINIA VIRUS DEFICIENT IN LARGE REGION OF GENES | BATES, KEENAN ALEXANDER | 1631 | §102 | Non-Final OA | — | Pending | Mar 24, 2023 |
| 18023957 | ANTIBODY AGAINST CORONAVIRUS | TAYLOR, LIA ELAN | 1641 | §102§103§112 | Final Rejection | 19d | Pending | Feb 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial